跳至主要内容
临床试验/NCT03967600
NCT03967600招募中不适用

Clinical and Biological Characteristics of Hidradenitis Suppurativa

University of California, San Francisco1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2016年7月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,000
试验地点
1
主要终点
The primary aim of this study is to identify clinical and biologic characteristics of hidradenitis suppurativa.

研究概览

简要总结

Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
13 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Hidradenitis Suppurativa Patients
  • Inclusion Criteria:
  • Age 13 years or older
  • Diagnosis of HS clinically-confirmed by a physician

排除标准

  • 1. Inability to give informed consent or have a parent/guardian who is able and willing to give informed consent.
  • Healthy Volunteer
  • Inclusion Criteria:
  • No history of chronic skin conditions
  • No recent history of antibiotic use
  • Exclusion Criteria:
  • 1. Inability to give informed consent or have a parent/guardian who is able and willing to give informed consent.

研究组 & 干预措施

Hidradenitis Suppurativa Patients

Patients with physician diagnosed Hidradenitis Suppurativa

Healthy Volunteers

Healthy volunteers without any skin conditions or recent history of antibiotic use.

结局指标

主要结局

The primary aim of this study is to identify clinical and biologic characteristics of hidradenitis suppurativa.

时间窗: 2016-2026

次要结局

  • Secondary aims include correlating alterations in clinical and biological characteristics with disease status, and identifying genetic variants that predict disease progression or response to therapy.(2016-2026)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验